ArQule Inc. (NASDAQ:ARQL) announced that the Company will present at the Needham 13th Annual Healthcare Conference. The presentation will be web cast and may be accessed through the investor relations section of the Company’s website http://www.arqule.com. ArQule, Inc. (NASDAQ:ARQL) stock performance was -2.92% in last session and finished the day at $1.66. Traded volume was…
On Sep 30, Acasti Pharma Inc. (NASDAQ:ACST), announces top-line results for its pharmacokinetic (PK) trial evaluating the bioavailability and safety of CaPre® on healthy individuals taking single and multiple daily oral doses of the Corporation’s new investigational drug candidate composed of a patent-protected highly concentrated novel omega-3 phospholipid for the prevention and treatment of certain…
Twenty-First Century Fox, Inc. (NASDAQ:FOXA) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a report released on Tuesday. The firm currently has a $35.30 price objective on the stock. Zacks‘s price target suggests a potential upside of 2.50% from the stock’s previous close. Twenty-First Century Fox, Inc. (NASDAQ:FOXA) belongs to…
Lloyds Banking Group PLC (NYSE:LYG)‘s stock had its “buy” rating restated by research analysts at Investec in a report released on Tuesday. Lloyds Banking Group plc (NYSE:LYG) belongs to Financial sector. Its net profit margin is -4.90% and weekly performance is 2.59%. On last trading day company shares ended up $5.15. Lloyds Banking Group plc…
On 7 AUG OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced second quarter 2014 financial results. Revenue for the three and six months ended June 30, 2014 was $4.9 million and $16.7 million, respectively. This compares with $6.3 million and $11.4 million, respectively, in the same periods in 2013. Revenue earned in the second quarter of 2014 consists…
Johnson & Johnson (NYSE:JNJ) was the first major company from the drug manufacturing industry to post impressive second-quarter earnings. The NYSE ARCA Pharmaceutical Index is up almost 20.1% in the last year. So far in 2014, the index increased10%. Johnson & Johnson (NYSE:JNJ) belongs to Healthcare sector. Its net profit margin is 21.20% and weekly…
